Team:EPF-Lausanne/Our Project/Summary

From 2011.igem.org

(Difference between revisions)
(Characterisation)
Line 30: Line 30:
== Characterisation ==
== Characterisation ==
-
We decided to work with TetR, as a proof-of concept trascription factor characterization. We combined two approaches for characterizing our mutants, both ''in vitro'' and ''in vivo''. We started by testing the wild-type and went on with some of our 12 TetR mutants. The strategy we used consisted of:
+
We decided to work with TetR, as a proof-of concept trascription factor characterization. We characterised our mutants both ''in vitro'' and ''in vivo''. We started by testing the wild-type and went on with some of our 12 TetR mutants. The strategy we used consisted of:
''' 1) producing interesting TetR mutants
''' 1) producing interesting TetR mutants
-
The mutants were created by site-specific and PCR-induced mutagenesis; we introduced point mutations at key amino acids involved in DNA recognition, in an attempt to alter the specificity of the TetR mutants.
+
The mutants were created by site-specific and PCR-induced mutagenesis. Based on the literature, we introduced point mutations at key amino acids involved in DNA recognition, in an attempt to alter the specificity of the TetR mutants.  
''' 2) determining the binding energy landscape of each mutants
''' 2) determining the binding energy landscape of each mutants
-
This is the ''in vitro'' characterization, which was performed thank to a microfluidic chip. This technique, called MITOMI, allows parallel testing of one mutant with 756 different DNA sequences. The absolute binding energy is then measured, and an enoLOGO is generated.
+
This is the ''in vitro'' characterization, which was performed thanks to a microfluidic chip. The technique, called MITOMI, allows parallel testing of one mutant with 756 different DNA sequences. The absolute binding energy is then measured, and an enoLOGO is generated.
[[File:EPFL-MITOMI shot.png|400px]]
[[File:EPFL-MITOMI shot.png|400px]]
Line 60: Line 60:
[[File:EPFL_Comparison_char.png|500px]]
[[File:EPFL_Comparison_char.png|500px]]
-
 
We were able to change the specificity of some of our mutants; however this change was not big enough to have a fully orthogonal mutant that would not recognize the wild-type consensus sequence.
We were able to change the specificity of some of our mutants; however this change was not big enough to have a fully orthogonal mutant that would not recognize the wild-type consensus sequence.
{{:Team:EPF-Lausanne/Templates/Footer}}
{{:Team:EPF-Lausanne/Templates/Footer}}

Revision as of 21:17, 28 October 2011